Revenue rose 16.8% year-on-year to more than RON1.1 billion. Both service and sales revenue increased from RON59.6 million to RON61.4 million and from RON894.1 million to RON1.05 billion.
(English version by Loredana Fratila-Cristescu)
Pharmaceutical producer Zentiva (SCD.RO), a company suspended from trading pending delisting from the Bucharest Stock Exchange, following withdrawal of minority shareholders, made RON258.8 million net profit in 2024, an increase of 34.3% on 2023.